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The book Drug Therapy in Dilated Cardiomyopathy and Myocarditis is one of 11
volumes in a series of monographs on basic and clinical cardiology. It deals with the
traditional, novel, and experimental pharmacologic agents used to treat congestive
heart failure (CHF) and myocarditis, and with the relationship between these two
disorders.
The precise definition of dilated cardiomyopathy differs according to various
authors. The preface of this book begins by defining this form of congestive heart
failure and discussing its prevalence and possible etiologies. The editors state that
dilated cardiomyopathy is defined as a state in which "both ventricles are enlarged,
systolic function is reduced, and the coronary arteries are normal." They note a study
by Johnson and Palacious which estimates that this form ofcongestive heart failure is
10 to 25 percent as common as ischemic cardiomyopathy and that dilated cardiomy-
opathy is increasing in both prevalence and incidence. For this reason, they conclude
that a book on the drug therapy for dilated cardiomyopathy is valuable.
The book is divided into 15 chapters. The first three deal with the anatomy and
pathophysiology of the failing heart. The next five deal with traditional methods of
treatment, including digitalis, diuretics, and afterload-reducing agents. The next four
chapters deal with drugs such as dobutamine, levadopa, and beta blockers, which are
not yet used routinely to treat cardiomyopathies.
The description of the pathophysiology of CHF is a nice review, but the next nine
chapters on the forms of treatment are confusing. Many of the studies referred to in
thesechapters were studies in which ischemia was themajor causeofCHF. Thus, these
studies were not dealing with the dilated type of CHF which the editors profess to be
reviewing. In the preface, the editors stressed the significance of this volume as a
review of the pharmacologic therapy for non-ischemic dilated cardiomyopathy. In this
respect, the book failed.
Chapter 13, entitiled "Myocarditis as a cause of dilated cardiomyopathy," begins
with the statement, "The hypothesis that myocarditis may be a cause, ifnot the major
cause, ofdilated (congestive) cardiomyopathy has been posed repeatedly, and over the
years increasing evidence has been accumulated in its support." This statement further
implies that the initial 12 chapters were describing a different entity. In any event, this
chapter does provide interesting evidence that myocarditis may be a major cause of
dilated cardiomyopathy.
The following chapter discusses immunotherapy as a treatment and concludes with
the statement that it is unclear whether immunosuppression is ofany benefit in dilated
cardiomyopathy and that the current NIH study will determine its efficacy.
This book fails to discuss adequately what I consider to be the most crucial issue,
which is whether endomyocardial biopsy is diagnostic in determining which patients
have myocarditis. In a recent article in the Annals of Internal Medicine, J.T. Lie
suggested that the NIH multi-center trial may not be very useful because thediagnosis
ofmyocarditis by endomyocardial biopsy is enormously subjective and the interpreta-
tion ofthe biopsy has a very high inter-observer variability.
My last criticism of this volume is a technical one. In addition to the several
typographical errors and the incorrect reference in the preface, several pages in
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chapter 7 were printed out oforder. While this flaw may only be a careless oversight, it
adds to the reader's confusion, which is already significant.
In conclusion, Engelmeier and O'Connell, the editors of this book, define dilated
cardiomyopathy as distinct from ischemic cardiac disease. They claim that its inci-
dence is increasing, and that it is quite probably linked to myocarditis. They then
include papers from studies which do not discriminate between the ischemic and
dilated forms of cardiomyopathy, thereby undermining the presumed importance of
their book. For this reason, I do not recommend the volume.
HAL BARRON
MedicalStudent
Yale University School ofMedicine
THE PASTEURIZATION OF FRANCE. By Bruno Latour. Cambridge, MA, Harvard
University Press, 1988. 273 pp. $30.00.
It is a complex world, and the human mind is simple: we tend to simplify our
environment through generalizations and categorizations. In similar fashion, we
simplify history by dwelling on dates and facts and by attributing major events and
broad trends to the actions ofa few individuals. The Franco-Russian wars ofthe early
nineteenth century, including the battles of Moscow and Tarutino, have often been
attributed to the journeying of a single man, Napoleon, and his "Grande Armee."
Indeed, we often speak of the "Napoleonic Era." Latour points out the manner in
which Tolstoy reacted against that simplification, noting how Tolstoy's monumental
War and Peace was an attempt, in a mere eight hundred pages, to "give back to the
multitude the effectiveness that the historians of his century placed in the virtue or
genius of a few men." Likewise, Bruno Latour points to the recurrent fallacy in the
history ofscience of"the great man ... alone in his laboratory, alone with his concepts
... he revolutionizes the society around him by the power of his mind alone." This
reductionist scenario is far too simple; it ignores the broad forces and movements in
science and in society which both influence the revolutionary and which implement his
"revolution." In The PasteurizationofFrance, the author critically examines the myth
of Pasteur, a myth in which Pasteur is the leviathan who conquers the world of
microbes and, with his Germ Theory, single-handedly brings the French people and the
world into the Modern Age.
The Pasteurization ofFrance is presented in two parts. The first consists of three
major chapters and begins with the story ofthe rise ofthe hygienists in the latter part
of the nineteenth century. Latour sets out to prove that the microbiological revolution
(to borrow a political term) whichoccurred in the nineteenth century was not the result
of the genius of one lone scientist (Pasteur). Rather, the myth of Pasteur, which the
author refers to as the "Pasteurian hagiography," was invoked by the hygienists togain
power. Thus, the microbiological revolution was not a product of Pasteur, but rather,
"Pasteur" was a product of the microbiological revolution. Latour writes that "the
complete hybridization of hygienists and Pasteurians multiplied the power of both."
For the hygienic movement, the move to clean up cities, provide clean running water
and "flushing systems to evacuate excrement" now had a prophet. For the Pasteurians,
there was an increase in publicity, power, and public funds. Finally, for Pasteur